Zoetis Inc

Healthcare · Drug Manufacturers - Specialty & Generic

69.70$ +0.9% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Zoetis Inc (ZTS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 2,468 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ZTS
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	1,241	1,277	1,231	1,269	1,347	1,460	1,366	1,415	1,480	1,564	1,455	1,547	1,584	1,674	1,534	1,548	1,786	1,807	1,871	1,948	1,990	1,967	1,986	2,052	2,002	2,040	2,000	2,180	2,151	2,213	2,190	2,361	2,388	2,317	2,220	2,460	2,400	2,387	2,262	2,468	9,517
Cost of Revenue	429	487	464	462	458	480	470	470	505	583	556	504	517	570	499	491	586	641	589	609	626	640	610	662	644	688	625	644	676	765	680	703	736	741	654	682	715	743	641	673	2,772
Gross Profit	812	790	767	807	889	980	896	945	975	981	899	1,043	1,067	1,104	1,035	1,057	1,200	1,166	1,282	1,339	1,364	1,327	1,376	1,390	1,358	1,352	1,375	1,536	1,475	1,448	1,510	1,658	1,652	1,576	1,566	1,778	1,685	1,644	1,621	1,795	6,745
Research & Development	90	108	90	86	96	110	97	102	108	125	102	111	112	132	107	111	112	133	118	120	132	138	122	135	134	148	142	146	152	174	162	171	167	186	157	172	170	199	180	173	722
Selling, General & Administrative	345	242	309	336	328	207	338	359	367	262	369	406	391	305	389	393	424	285	409	495	504	301	465	529	501	227	505	556	525	284	547	581	565	625	563	617	579	619	588	592	2,378
Total Operating Expenses	435	469	399	424	424	471	435	461	446	545	471	517	503	604	496	504	536	653	527	615	636	731	587	664	635	662	647	702	677	739	709	752	732	811	720	789	749	818	799	858	3,224
Operating Income	377	321	368	383	465	509	461	484	529	436	428	526	564	500	539	553	664	513	755	724	728	596	789	726	723	690	728	834	798	709	801	906	920	765	846	989	936	826	822	937	3,521
Interest Expense	41	41	41	41	43	50	47	47	56	62	60	59	61	62	59	62	66	62	60	60	59	57	56	57	57	67	68	63	63	59	62	63	61	56	59	58	64	57	62	61	244
Pre-Tax Income	333	231	337	345	413	430	417	437	418	418	381	455	528	437	497	482	597	420	687	636	659	506	727	670	667	592	697	872	717	650	747	780	874	732	810	902	887	761	758	866	3,272
Income Tax Expense	96	77	98	98	117	350	67	55	71	73	69	84	95	53	74	106	118	62	129	125	107	93	133	141	139	132	146	202	121	127	148	156	182	151	179	184	166	158	157	175	656
Net Income	239	154	238	247	298	81	352	384	347	345	312	371	433	384	423	377	479	359	559	512	552	414	595	529	529	461	552	671	596	525	599	624	682	581	631	718	721	603	601	691	2,616
EBITDA	434	335	440	445	514	543	524	547	558	581	539	612	696	608	666	655	774	591	856	808	828	680	897	844	839	778	885	1,056	904	835	935	970	1,056	911	988	1,083	1,069	939	939	927	3,874

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings